Vaccines could be OKed for emergency use in kids under 12 in early to midwinter: FDA

People walk by a sign that reads, "Now available! COVID-19 vaccine" in TriBeCa on May 27, 2021 in New York City. On May 19, all pandemic restrictions, including mask mandates, social distancing guidelines, venue capacities and restaurant curfews were lifted by New York Governor Andrew Cuomo.
People walk by a sign that reads, "Now available! COVID-19 vaccine" in TriBeCa on May 27, 2021 in New York City. On May 19, all pandemic restrictions, including mask mandates, social distancing guidelines, venue capacities and restaurant curfews were lifted by New York Governor Andrew Cuomo. Photo credit Noam Galai/Getty Images

COVID-19 vaccines could be approved for emergency use in kids under 12 years old in early to midwinter, a Food and Drug Administration official said Thursday.

The federal agency then hopes it can fully approv vaccines kids, NBC News reported.

Pfizer-BioNTech and Moderna kicked off trials of their COVID-19 vaccines for kids under 12 in March. The results from those trials won't be in until the fall, though. Then, the FDA will review the drug companies' applications.

The FDA has asked for four to six months of safety follow-up data for kids, as opposed to two months of follow-up data for the clinical trials in adults.

Related

San Francisco won't follow LA County's lead, but could update guidance
San Francisco won't follow LA County's lead, but could update guidance
Featured Image Photo Credit: Noam Galai/Getty Images